Heart Disease News and Research

Latest Heart Disease News and Research

School kids need 60 minutes or more of moderate to vigorous physical activity daily

"The take-home message for parents is that it is very important to ensure that their children spend at least an hour a day in some form of appropriate physical activity," says Dr. William B. Strong, a pediatric cardiologist and retired professor at the Medical College of Georgia who co-chaired the panel.

13 Jun 2005

Short-term use of CPAP therapy may protect against cardiovascular disease

A common sleep therapy used to treat patients with obstructive sleep apnea (OSA) may actually have a protective effect against death related to cardiovascular disease.

13 Jun 2005

Circadian clock gene also plays pivotal role in drug addiction

The gene that regulates the body's main biological clocks also may play a pivotal role in drug addiction, researchers at UT Southwestern Medical Center have found.

13 Jun 2005

Teen-age boys with type 1 diabetes showed evidence of greater atherosclerosis

Youths with type 1 diabetes, especially boys, already show early signs of cardiovascular disease by their teen-age years, according to researchers from the Keck School of Medicine of the University of Southern California and Childrens Hospital Los Angeles.

13 Jun 2005

Only 12 percent of pediatricians surveyed felt effective in treating overweight children

If North Carolina reflects what is happening nationally, most pediatricians across the country lack confidence in their ability to treat obesity, which is increasingly recognized as robbing children of physical vigor now and good health in later life, a new study shows.

13 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes -- all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Researchers discover how microRNA are involved in the development of heart muscle

Researchers at UT Southwestern Medical Center have discovered how a small molecule of RNA called microRNA - a chemical cousin of DNA - helps fine tune the production of a key protein involved in the early development of heart muscle.

12 Jun 2005

Genetic variations predispose Mexican Americans to insulin resistance

Although numerous studies have shown that low-grade inflammation is linked to heart disease and diabetes, more recent studies have shown that inflammation plays a role in insulin resistance, a syndrome that leads to diabetes and heart disease and affects about one in four adults in the United States.

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

Researchers in the UK are saying that some of the most commonly used painkillers are more likely to cause heart attacks than Vioxx, the arthritis drug withdrawn from the market last year after it was linked to heart disease.

12 Jun 2005

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Patients should not stop taking the drugs involved - non-steroidal anti-inflammatory drugs (NSAIDS) - but further investigation into these treatments is needed, say the authors.

10 Jun 2005

Survey highlights need for primary care guidance on NSAID use

New guidance on NSAID (non-steroidal anti-inflammatory drug) use is urgently needed to ensure the best patient care, European experts said today. The news coincides with the results from a European survey of 626 arthritis patients which found that many are confused and worried about the potential side-effects of their medication.

10 Jun 2005

Heart Disease News and Research

Latest Heart Disease News and Research

School kids need 60 minutes or more of moderate to vigorous physical activity daily

Short-term use of CPAP therapy may protect against cardiovascular disease

Circadian clock gene also plays pivotal role in drug addiction

Teen-age boys with type 1 diabetes showed evidence of greater atherosclerosis

Only 12 percent of pediatricians surveyed felt effective in treating overweight children

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Researchers discover how microRNA are involved in the development of heart muscle

Genetic variations predispose Mexican Americans to insulin resistance

Link between PKC enzyme and kidney disease in diabetes confirmed

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Survey highlights need for primary care guidance on NSAID use

Ibuprofen may cause heart attacks - full disclosure of all data - including industry safety data - is essential

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Private health insurance given the go-ahead in Canada

Intensive therapy, even four years later, improves stroke victims speech

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Heart Disease News and Research

Latest Heart Disease News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in